Stay up-to-date with the Divis Labs Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Divis Laboratories benefits from strong CDMO demand but faces high valuations, prompting a hold recommendation for investors.

Discover the Divis Labs Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Divis Lab trading at ₹3292.95, up 0.5% from yesterday's ₹3276.5 As of the latest trading day, Divis Lab's stock has a current price of ₹3292.95, which represents a 0.5% increase from the previous ...

US Department of Defense's listing of Chinese firms as military-linked boosts prospects for Indian pharma CRDMOs like Sai Life Sciences and Divi's Laboratories, highlighting growth in small-molecule ...

Divis Labs’ revenue for the quarter amounted to Rs. 2,238 crore, marking a 17% y-o-y increase and a 6% q-o-q rise, which was 4% above estimates. EBITDA stood at Rs. 616 crore, reflecting a 29% y-o-y ...

Macquarie have chosen four pharma stocks that can provide up to 30 per cent returns. The analysts have given outperform ...

Divis Laboratories’ net profit declined 29 percent at ₹348 crore in the second quarter of the current financial year ended September 30, 2023, against ₹493 crore in the corresponding quarter of the ...

Divis Laboratories Ltd is down for a fifth straight session today. The stock is quoting at Rs 3451.3, down 2.29% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.24% on the ...

Divis Lab trading at ₹3260.15, down -0.56% from yesterday's ₹3278.6 As of the current data, the price of Divis Lab stock is ₹3260.15, indicating a decline of 0.56% from the previous trading day. The ...